PROSORBA COLUMN

FDA Premarket Approval P850020 S019

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for several changes to the ra-4 post-approval study protocol. Specifically, these are: 1) a change in inclusion criterion 6 to allow the enrollment of patients who have been on methotrexate (>= 15 mg/week) for at least three months prior to screening, rather than six months prior to screening; 2) the addition of an inclusion criterion to allow the enrollment of patients who have had toxicity to methotrexate at a dose of >= 15 mg/week if they can be on a dose of 12. 5 mg/week; 3) the inclusion of patients receiving concomitant treatment with other disease-modifying anti-rheumatic drugs (dmards); and 4) the inclusion of patients with 12 or more joints tender or painful on motion or pressure, rather than 16 such joints.

DevicePROSORBA COLUMN
Generic NameSeparator, Automated, Blood Cell And Plasma, Therapeutic
ApplicantFRESENIUS HEMOCARE, INC.
Date Received2003-10-17
Decision Date2004-04-14
PMAP850020
SupplementS019
Product CodeLKN 
Advisory CommitteeGastroenterology/Urology
Supplement TypeNormal 180 Day Track No User Fee
Supplement ReasonPostapproval Study Protocol - Ode/oir
Expedited ReviewNo
Combination Product No
Applicant Address FRESENIUS HEMOCARE, INC. 920 Winter Street waltham, MA 02451

Supplemental Filings

Supplement NumberDateSupplement Type
P850020Original Filing
S024 2006-09-18 Special (immediate Track)
S023 2006-04-14 Special (immediate Track)
S022 2006-03-31 Special (immediate Track)
S021 2005-07-26 Special (immediate Track)
S020 2005-07-01 Normal 180 Day Track No User Fee
S019 2003-10-17 Normal 180 Day Track No User Fee
S018 2003-04-30 30-day Notice
S017 2003-04-15 Special (immediate Track)
S016 2002-08-16 Normal 180 Day Track
S015 2002-04-15 30-day Notice
S014 2001-08-07 30-day Notice
S013 2001-04-30 Normal 180 Day Track
S012 1999-06-21 Normal 180 Day Track
S011 1998-07-21 Panel Track
S010
S009 1997-03-07 Normal 180 Day Track
S008 1994-08-12 Normal 180 Day Track
S007
S006 1993-03-15 Normal 180 Day Track
S005 1993-03-09 Normal 180 Day Track
S004 1992-02-03 Normal 180 Day Track
S003 1990-07-31 Normal 180 Day Track
S002
S001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.